K. Berg and F. Guillemin, Enhanccd gene transfer and ccII death follo\Ving l'53 gene transfer using photochemical internalisation of glucosylatcd PEI-D A complexes, Gene Med, vol.6, issue.1, pp.884-894, 2004.

P. Erbacher, T. Betlinger, and P. Bclguise, Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI), The Journal of Gene Medicine, vol.4, issue.3, pp.210-222, 1999.
DOI : 10.1042/bj1730723

P. Sclbo, G. Sivam, and O. Fodstad, Pholoehemical internalisation inereases Ihe cytolOxic cffecl of the immunotoxin MOC31-Gclonin, Inl J Cnneer, vol.87, pp.853-859, 2000.

C. Didelot and J. Mirjolct, B<lrberi-I-Ieyob M. el al: Oncoprotein expression of E6 and E7 does nol prevenl 5-11uorouracil (5FU) mediated G liS arrcsl and apoplosis in 5FU rcsistalll eareinoma ccli lines, Int J, vol.23, pp.81-87, 2003.

M. Zallla and O. Boussif, Adib 1\. el (II: III vÎlro dclivery 10 hepmo· cyles \Vith galaclosyled polyclhylcneimine, Bioconjugate Chelll, vol.8, pp.839-844, 1997.

A. Bonsled, B. Engcsacter, and A. Iogset, el al: Transgene expression Îs increased by photochemically lllcdiated transduction of polycation-complexed adenoviruses. Gene Thel' II, pp.152-160, 2004.

E. Brown, Y. Boucher, and R. Nasser-sand-jain, Measurement of macromolecular diffusion coefficients in human tumors, Microvascular Research, vol.67, issue.3, pp.231-236, 2004.
DOI : 10.1016/j.mvr.2004.02.001

P. Bllligereit, F. Schakowski, and A. Marten, el al: Effects of adelloviral \Vild-typc"p53 gene transfer in p53-mlltaled Iymphoma cells, Cancer Gene Thel, vol.8, pp.430-439, 2001.

M. Jr, :. Didelot, and C. , Barbcri-I-Icyob M. el lIl: G(I)/S bUI not G(O)lG( I)ccll fraction is rclaled to 5-11uorouracil cytoloxicity, Cyloll1WY, vol.48, pp.6-13, 2002.

E. and P. Expression, EGFR overexpression was observed in PC3 cells (fig 2A) No PTEN expression was observed (fig 2B) Following gene transfer, pten gene was found to be restored (fig 2B)

R. , R. /. Mapk, and P. , AKT signaling Constitutive overexpression of phosphorylated-AKT (p-AKT) and consequent overexpression of AKT downstream signaling phosphoproteins, phosphorylated-GSK3 (p-GSK3 and phosphorylated-P70S6K (p-P70S6K) was observed in untransfected control cells as awaited in relation with pten-null phenotype (fig 3) Constitutive overexpression of

J. Mendelsohn and J. Baselga, The EGF receptor family as targets for cancer therapy, Oncogene, vol.19, issue.56
DOI : 10.1073/pnas.94.18.9562

Y. Yarden, The EGFR family and its ligands in human cancer, European Journal of Cancer, vol.37, pp.3-8, 2001.
DOI : 10.1016/S0959-8049(01)00230-1

A. Lièvre, J. Bachet, L. Corre, and D. , Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer, Cancer Research, vol.66, issue.8, pp.3992-3995, 2006.
DOI : 10.1158/0008-5472.CAN-06-0191

A. Lièvre, J. Bachet, and V. Boige, Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab, Journal of Clinical Oncology, vol.26, issue.3, pp.374-379, 2008.
DOI : 10.1200/JCO.2007.12.5906

J. Merlin, G. Perkins, and A. Lièvre, Additonal value of EGFR downstream signaling phosphoprotein expression to K-Ras mutation for response prediction to cetuximab in colorectal cancer, J Clin Oncol, vol.26, p.209, 2008.

N. Cho, M. Choi, B. Kim, Y. Cho, K. Moon et al., BRAF andKRAS mutations in prostatic adenocarcinoma, International Journal of Cancer, vol.129, issue.8, pp.1858-1862, 2006.
DOI : 10.1111/j.1349-7006.2002.tb01318.x

M. Mcmenamin, P. Soung, S. Perera, I. Kaplan, M. Loda et al., Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage, Clin Cancer Res, vol.59, pp.4291-4296, 1999.

T. Maehama and J. Dixon, The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate, Journal of Biological Chemistry, vol.317, issue.22, pp.13375-13378, 1998.
DOI : 10.1016/S0092-8674(00)80272-X

K. Sakata, S. Kato, J. Fox, M. Shigemori, and M. Morimatsu, Autocrine Signaling through Ras Regulates Cell Survival Activity in Human Glioma Cells: Potential Cross-Talk between Ras and the Phosphatidylinositol 3-Kinase-Akt Pathway, Journal of Neuropathology & Experimental Neurology, vol.25, issue.11, pp.975-983, 2002.
DOI : 10.1017/S0317167100034272

M. Frattini, P. Saletti, and E. Romagnani, PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients, British Journal of Cancer, vol.24, issue.8, pp.1139-1184, 2007.
DOI : 10.1016/j.ctrv.2003.10.003

C. Schimanski, U. Linnemann, and M. Berger, Sensitive detection of K-Ras mutations augments diagnosis of colorectal cancer metastases in the liver, Cancer Res, vol.59, pp.5169-5175, 1999.

A. Maurice-duelli, A. Ndoye, S. Bouali, A. Leroux, and J. Merlin, Enhanced Cell Growth Inhibition following PTEN Nonviral Gene Transfer Using Polyethylenimine and Photochemical Internalization in Endometrial Cancer Cells, Technology in Cancer Research & Treatment, vol.58, issue.5, pp.459-465, 2004.
DOI : 10.1002/1097-0215(20000915)87:6<853::AID-IJC15>3.0.CO;2-0

A. Chrétien, F. Chergui, and T. Bastogne, Validation of phosphoprotein array assay for the determination of human epidermal growth factor receptors downstream signaling phosphoproteins in breast cancer, Eur J Cancer, vol.9, issue.96, 2008.

R. Sharrard and N. Maitland, Phenotypic effects of overexpression of the MMAC1 gene in prostate epithelial cells, British Journal of Cancer, vol.83, issue.8, pp.1102-1109, 2000.
DOI : 10.1054/bjoc.2000.1400

Z. Wu, T. Song, D. Li, X. Zhang, and X. Wu, Overexpression of PTEN Suppresses Growth and Induces Apoptosis by Inhibiting the Expression of Survivin in Bladder Cancer Cells, Tumor Biology, vol.24, issue.1, pp.9-15, 2006.
DOI : 10.1172/JCI200113345

A. Astanehe, D. Arenillas, and W. Wasserman, Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer, Journal of Cell Science, vol.121, issue.5, pp.664-674, 2008.
DOI : 10.1242/jcs.013029

X. Li, R. Luwor, Y. Lu, K. Liang, and Z. Fan, Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells, Oncogene, vol.25, issue.4, pp.525-535, 2006.
DOI : 10.1038/sj.onc.1209075

Y. Nagata, K. Lan, and X. Zhou, PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients, Cancer Cell, vol.6, issue.2, pp.117-127, 2004.
DOI : 10.1016/j.ccr.2004.06.022

J. Merlin, P. Genin, and A. Harle, Phosphoprotein Array in tumor biopsies for molecular diagnostis of PI3 Kinase and MAP Kinase signaling functionality, Mol. Cancer Ther, vol.6, p.3540, 2007.

J. Merlin, E. Longavenne, and F. Chergui, Exploring human epidermal growth factor receptors downstream signaling by multiplex phosphoprotein determination in breast cancer

J. Merlin, J. Mriouah, and G. Dolivet, Signaling phosphoproteins in head and neck squamous cell carcinoma: relation with cellular sensitivity to cetuximab and interest of multiplex determination using Bio-Plex protein array, Proc Amer Assoc Cancer Res, vol.48, issue.185, 2007.

M. Davies, S. Kim, N. Parikh, Z. Dong, C. Bucana et al., Adenoviralmediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells, Clin Cancer Res, vol.8, pp.1904-1918, 2002.

E. Mcrae, A. Giannoudis, and R. Ryan, Gene therapy for prostate cancer: Current strategies and new cell-based approaches, The Prostate, vol.174, issue.5, pp.470-494, 2006.
DOI : 10.4049/jimmunol.174.6.3798

J. Merlin and P. , PhD Unité de Biologie des Tumeurs Centre Alexis Vautrin Avenue de Bourgogne 54511 Vandoeuvre-lès-Nancy cedex

J. Mendelsohn and J. Baselga, The EGF receptor family as targets for cancer therapy, Oncogene, vol.19, issue.56
DOI : 10.1073/pnas.94.18.9562

M. Prewett, P. Rockwell, R. Rockwell, N. Giorgio, J. Mendelsohn et al., The Biologic Effects of C225, A Chimeric Monoclonal Antibody to the EGFR, on Human Prostate Carcinoma, Journal of Immunotherapy, vol.19, issue.6, pp.419-446, 1996.
DOI : 10.1097/00002371-199611000-00006

F. Sirotnak, M. Zakowski, V. Miller, H. Scher, and M. Kris, Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase, Clin Cancer Res, vol.6, pp.4885-92, 2000.

Y. Yarden, The EGFR family and its ligands in human cancer, European Journal of Cancer, vol.37, pp.3-8, 2001.
DOI : 10.1016/S0959-8049(01)00230-1

W. Lei, J. Mayotte, and M. Levitt, Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells, Anticancer Res, vol.19, pp.221-229, 1999.

M. Fukuoka, S. Yano, G. Giaccone, T. Tamura, K. Nakagawa et al., Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.21, issue.12, pp.2237-2283, 2003.
DOI : 10.1200/JCO.2003.10.038

R. Herbst, Review of epidermal growth factor receptor biology, International Journal of Radiation Oncology*Biology*Physics, vol.59, issue.2, pp.21-27, 2004.
DOI : 10.1016/j.ijrobp.2003.11.041

I. Lebedeva, Z. Su, D. Sarkar, and P. Fisher, Restoring apoptosis as a strategy for cancer gene therapy: focus on p53 and mda-7, Seminars in Cancer Biology, vol.13, issue.2, pp.169-78, 2003.
DOI : 10.1016/S1044-579X(02)00134-7

J. Rho, Y. Choi, B. Ryoo, I. Na, S. Yang et al., p53 enhances gefitinibinduced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancer

A. Huether, M. Höpfner, V. Baradari, D. Schuppan, and H. Scherübl, EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer, Biochemical Pharmacology, vol.70, issue.11
DOI : 10.1016/j.bcp.2005.09.007

B. Singh, P. Reddy, A. Goberdhan, C. Walsh, S. Dao et al., p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas, Genes & Development, vol.16, issue.8, pp.984-93, 2002.
DOI : 10.1101/gad.973602

N. Kalra, K. Seth, S. Prasad, M. Singh, A. Pant et al., Theaflavins induced apoptosis of LNCaP cells is mediated through induction of p53, down-regulation of NF-kappa B and mitogen-activated protein kinases pathways, Life Sciences, vol.80, issue.23, pp.2137-2183, 2007.
DOI : 10.1016/j.lfs.2007.04.009

J. Li, Y. C. Liaw, D. Bose, S. Wang, S. Puc et al., PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer, Science, vol.275, issue.5308, pp.1943-1950, 1997.
DOI : 10.1126/science.275.5308.1943

M. Mcmenamin, P. Soung, S. Perera, I. Kaplan, M. Loda et al., Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage, Clin Cancer Res, vol.59, pp.4291-4297, 1999.

T. Maehama and J. Dixon, The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate, Journal of Biological Chemistry, vol.317, issue.22, pp.13375-13383, 1998.
DOI : 10.1016/S0092-8674(00)80272-X

J. Li, L. Simpson, M. Takahashi, C. Miliaresis, M. Myers et al., The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene, Cancer Res, vol.58, pp.5667-72, 1998.

V. Stambolic, A. Suzuki, J. De-la-pompa, G. Brothers, C. Mirtsos et al., Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN, Cell, vol.95, issue.1, pp.29-39, 1998.
DOI : 10.1016/S0092-8674(00)81780-8

M. Frattini, P. Saletti, E. Romagnani, V. Martin, F. Molinari et al., PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients, British Journal of Cancer, vol.24, issue.8, pp.1139-1184, 2007.
DOI : 10.1016/j.ctrv.2003.10.003

Q. She, D. Solit, A. Basso, and M. Moasser, Resistance to gefitinib in PTEN-null HERoverexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3' -kinase/AKT pathway signalling, Cancer Res, vol.9, pp.4340-4346, 2003.

A. Ndoye, S. Bouali, G. Dolivet, A. Leroux, P. Erbacher et al., Sustained gene transfer and enhanced cell death following glucosylated-PEI-mediated p53 gene transfer with photochemical internalisation in p53-mutated head and neck carcinoma cells, International Journal of Oncology, vol.25, pp.1575-81, 2004.
DOI : 10.3892/ijo.25.6.1575

A. Maurice-duelli, A. Ndoye, S. Bouali, A. Leroux, and J. Merlin, Enhanced Cell Growth Inhibition following PTEN Nonviral Gene Transfer Using Polyethylenimine and Photochemical Internalization in Endometrial Cancer Cells, Technology in Cancer Research & Treatment, vol.58, issue.5, pp.459-65, 2004.
DOI : 10.1002/1097-0215(20000915)87:6<853::AID-IJC15>3.0.CO;2-0

A. Ndoye, G. Dolivet, A. Hogset, A. Leroux, A. Fifre et al., Eradication of p53-Mutated Head and Neck Squamous Cell Carcinoma Xenografts Using Nonviral p53 Gene Therapy and Photochemical Internalization, Molecular Therapy, vol.13, issue.6, pp.1156-62, 2006.
DOI : 10.1016/j.ymthe.2006.02.003

URL : https://hal.archives-ouvertes.fr/hal-00129944

I. Logan, H. Mcneill, S. Cook, X. Lu, J. Lunec et al., Analysis of the MDM2 antagonist nutlin-3 in human prostate cancer cells, The Prostate, vol.281, issue.8, pp.900-906, 2007.
DOI : 10.1002/pros.20568

R. Sharrard and N. Maitland, Phenotypic effects of overexpression of the MMAC1 gene in prostate epithelial cells, British Journal of Cancer, vol.83, issue.8, pp.1102-1111, 2000.
DOI : 10.1054/bjoc.2000.1400

X. Li, R. Luwor, Y. Lu, K. Liang, and Z. Fan, Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells, Oncogene, vol.25, issue.4, pp.525-560, 2006.
DOI : 10.1038/sj.onc.1209075

Z. Wu, T. Song, D. Li, X. Zhang, and X. Wu, Overexpression of PTEN Suppresses Growth and Induces Apoptosis by Inhibiting the Expression of Survivin in Bladder Cancer Cells, Tumor Biology, vol.24, issue.1, pp.9-15, 2006.
DOI : 10.1172/JCI200113345

J. Merlin, G. Dolivet, C. Dubessy, E. Festor, R. Parache et al., Improvement of nonviral p53 gene transfer in human carcinoma cells using glucosylated polyethylenimine derivatives, Cancer Gene Therapy, vol.8, issue.3, pp.203-213, 2001.
DOI : 10.1038/sj.cgt.7700289

A. Ndoye, J. Merlin, A. Leroux, G. Dolivet, P. Erbacher et al., Enhanced gene transfer and cell death following p53 gene transfer using photochemical internalisation of glucosylated PEI-DNA complexes, The Journal of Gene Medicine, vol.6, issue.8, pp.884-94, 2004.
DOI : 10.1002/jgm.573

M. Davies, S. Kim, N. Parikh, Z. Dong, C. Bucana et al., Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells, Clin Cancer Res, vol.8, pp.1904-1918, 2002.

H. Tanaka, N. Fujita, and T. Tsuruo, 3-Phosphoinositide-dependent Protein Kinase-1-mediated I??B Kinase ?? (IKKB) Phosphorylation Activates NF-??B Signaling, Journal of Biological Chemistry, vol.63, issue.49, pp.40965-73, 2005.
DOI : 10.1126/science.281.5385.2042

A. Lièvre, J. Bachet, L. Corre, D. Boige, V. Landi et al., Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer, Cancer Research, vol.66, issue.8, pp.3992-3997, 2006.
DOI : 10.1158/0008-5472.CAN-06-0191

J. Merlin, P. Genin, A. Harle, G. Giagometti, F. Chergui et al., Phosphoprotein Array in tumor biopsies for molecular diagnostis of PI3 Kinase and MAP Kinase signaling functionality, Mol. Cancer Ther, vol.6, p.3540, 2007.

J. Merlin, E. Longavenne, F. Chergui, C. Ramacci, M. Rouyer et al., Exploring human epidermal growth factor receptors downstream signaling by multiplex phosphoprotein determination in breast cancer, Proc Amer Assoc Cancer Res, vol.47, 2006.

J. Merlin, J. Mriouah, and G. Dolivet, Signaling phosphoproteins in head and neck squamous cell carcinoma: relation with cellular sensitivity to cetuximab and interest of multiplex determination using Bio-Plex protein array, Proc Amer Assoc Cancer Res, vol.48, 2007.

E. Vattemi and P. Claudio, Adenoviral gene therapy in head and neck cancer, Drug News & Perspectives, vol.19, issue.6, pp.329-366, 2006.
DOI : 10.1358/dnp.2006.19.6.1015352

J. M. Adams and S. Cory, The Bcl-2 Protein Family: Arbiters of Cell Survival, Science, vol.281, issue.5381, pp.1322-1328, 1998.
DOI : 10.1126/science.281.5381.1322

M. L. Agarwal and A. Agarwal, p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts., Proceedings of the National Academy of Sciences, vol.92, issue.18, pp.92-8493, 1995.
DOI : 10.1073/pnas.92.18.8493

Y. Ahn and C. Y. Hwang, The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4, Biochemical Journal, vol.412, issue.2, pp.331-339, 2008.
DOI : 10.1042/BJ20071403

A. Akinc and M. Thomas, Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis, The Journal of Gene Medicine, vol.70, issue.5, pp.657-63, 2005.
DOI : 10.1007/BF02789334

A. M. Al-khouri and Y. Ma, Cooperative Phosphorylation of the Tumor Suppressor Phosphatase and Tensin Homologue (PTEN) by Casein Kinases and Glycogen Synthase Kinase 3??, Journal of Biological Chemistry, vol.5, issue.42, pp.35195-202, 2005.
DOI : 10.1074/jbc.M504761200

L. D. Attardi and E. E. Reczek, PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family, Genes Dev, vol.14, issue.6, pp.704-722, 2000.

E. I. Azzam and S. M. De-toledo, CDC2 is down-regulated by ionizing radiation in a p53-dependent manner, Cell Growth Differ, vol.8, issue.11, pp.1161-1170, 1997.

S. J. Baker and E. R. Fearon, Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas, Science, vol.244, issue.4901, pp.217-238, 1989.
DOI : 10.1126/science.2649981

Y. Barak and T. Juven, mdm2 expression is induced by wild type p53 activity, Embo J, vol.12, issue.2, pp.461-469, 1993.

D. Barford and A. J. Flint, Crystal structure of human protein tyrosine phosphatase 1B, Science, vol.263, issue.5152, pp.1397-404, 1994.
DOI : 10.1126/science.8128219

N. A. Barlev and L. Liu, Acetylation of p53 Activates Transcription through Recruitment of Coactivators/Histone Acetyltransferases, Molecular Cell, vol.8, issue.6, pp.1243-54, 2001.
DOI : 10.1016/S1097-2765(01)00414-2

K. Berg and L. Prasmickaite, Photochemical internalization (PCI)--a novel technology for release of macromolecules from endocytic vesicles, Oftalmologia, vol.56, issue.1, pp.67-71, 2003.

K. Berg and P. K. Selbo, Photochemical Internalization, Cancer Res, vol.59, issue.6, pp.1180-1183, 1999.
DOI : 10.1201/b15582-42

URL : https://hal.archives-ouvertes.fr/hal-00129944

R. Bianco and I. Shin, Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors, Oncogene, vol.22, issue.18, pp.2812-2834, 2003.
DOI : 10.1038/ncb1101-973

T. Bieber and W. Meissner, Intracellular route and transcriptional competence of polyethylenimine???DNA complexes, Journal of Controlled Release, vol.82, issue.2-3, pp.441-54, 2002.
DOI : 10.1016/S0168-3659(02)00129-3

J. R. Bischoff and P. N. Friedman, Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2., Proceedings of the National Academy of Sciences, vol.87, issue.12, pp.4766-70, 1990.
DOI : 10.1073/pnas.87.12.4766

J. R. Bischoff and D. H. Kirn, An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells, Science, vol.274, issue.5286, pp.373-379, 1996.
DOI : 10.1126/science.274.5286.373

W. F. Bodmer and S. Cottrell, Genetic analysis of colorectal cancer, Princess Takamatsu Symp, vol.20, pp.49-59, 1989.

O. Boussif and F. Lezoualc-'h, A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine., Proceedings of the National Academy of Sciences, vol.92, issue.16, pp.92-7297, 1995.
DOI : 10.1073/pnas.92.16.7297

S. D. Boyd and K. Y. Tsai, An intact HDM2 RING-finger domain is required for nuclear exclusion of p53, Nature Cell Biology, vol.18, issue.9, pp.563-571, 2000.
DOI : 10.1093/emboj/18.1.22

J. A. Brennan and D. Sidransky, Molecular staging of head and neck squamous carcinoma, Cancer and Metastasis Review, vol.120, issue.1, pp.3-10, 1996.
DOI : 10.1001/archotol.1994.01880330029006

A. N. Bullock and A. R. Fersht, Rescuing the function of mutant p53, Nature Reviews Cancer, vol.1, issue.1, pp.68-76, 2001.
DOI : 10.1038/35094077

F. Bunz and A. Dutriaux, Requirement for p53 and p21 to Sustain G2 Arrest After DNA Damage, Science, vol.282, issue.5393, pp.1497-501, 1998.
DOI : 10.1126/science.282.5393.1497

T. F. Burns and E. J. Bernhard, Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo, Oncogene, vol.20, issue.34, pp.4601-4613, 2001.
DOI : 10.1016/S0092-8674(00)80501-2

V. J. Bykov and N. Issaeva, Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound, Nature Medicine, vol.24, issue.3, pp.282-290, 2002.
DOI : 10.1093/nar/24.18.3560

P. Cairns and K. Okami, Frequent inactivation of PTEN/MMAC1 in primary prostate cancer, Cancer Res, vol.57, issue.22, pp.4997-5000, 1997.

E. R. Camp and J. Summy, Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptor, Clin Cancer Res, vol.11, issue.1, pp.397-405, 2005.

E. Caramelli and A. Matteucci, Nuclear phosphoinositide-specific phospholipase C, phosphatidylinositol 4,5-bisphosphate and protein kinase C during rat spermatogenesis, Eur J Cell Biol, vol.71, issue.2, pp.154-64, 1996.

G. Carpenter and S. Cohen, Epidermal growth factor, J Biol Chem, vol.265, issue.14, pp.7709-7721, 1990.

J. Chen and V. Marechal, Mapping of the p53 and mdm-2 interaction domains., Molecular and Cellular Biology, vol.13, issue.7, pp.4107-4121, 1993.
DOI : 10.1128/MCB.13.7.4107

J. Y. Chow and K. T. Quach, RAS/ERK modulates TGF??-regulated PTEN expression in human pancreatic adenocarcinoma cells, Carcinogenesis, vol.28, issue.11, pp.2321-2328, 2007.
DOI : 10.1093/carcin/bgm159

S. Chuikov and J. K. Kurash, Regulation of p53 activity through lysine methylation, Nature, vol.50, issue.7015, pp.353-60, 2004.
DOI : 10.1107/S0907444994003112

J. H. Chung and C. Eng, Nuclear-Cytoplasmic Partitioning of Phosphatase and Tensin Homologue Deleted on Chromosome 10 (PTEN) Differentially Regulates the Cell Cycle and Apoptosis, Cancer Research, vol.65, issue.18, pp.8096-100, 2005.
DOI : 10.1158/0008-5472.CAN-05-1888

J. H. Chung and M. E. Ginn-pease, Phosphatase and Tensin Homologue Deleted on Chromosome 10 (PTEN) Has Nuclear Localization Signal???Like Sequences for Nuclear Import Mediated by Major Vault Protein, Cancer Research, vol.65, issue.10, pp.4108-4124, 2005.
DOI : 10.1158/0008-5472.CAN-05-0124

J. H. Chung and M. C. Ostrowski, The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation, Human Molecular Genetics, vol.59, issue.17, pp.2553-2562, 2006.
DOI : 10.1074/jbc.270.40.23589

G. L. Clayman and A. K. Naggar, Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma., Journal of Clinical Oncology, vol.16, issue.6, pp.2221-2253, 1998.
DOI : 10.1200/JCO.1998.16.6.2221

S. Cohen and H. Ushiro, A native 170,000 epidermal growth factor receptorkinase complex from shed plasma membrane vesicles, J Biol Chem, vol.257, issue.3, pp.1523-1554, 1982.

K. M. Connor and S. Subbaram, Regulates the Angiogenic Phenotype via PTEN Oxidation, Journal of Biological Chemistry, vol.318, issue.17, pp.16916-16940, 2005.
DOI : 10.1146/annurev.bi.64.070195.000525

S. Cory and J. M. Adams, The bcl2 family: regulators of the cellular life-or-death switch, Nature Reviews Cancer, vol.2, issue.9, pp.647-56, 2002.
DOI : 10.1038/nrc883

L. V. Crawford and D. C. Pim, Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein., Proceedings of the National Academy of Sciences, vol.78, issue.1, pp.41-46, 1981.
DOI : 10.1073/pnas.78.1.41

C. V. Dang and W. M. Lee, Nuclear and nucleolar targeting sequences of c-erb-A, cmyb , N-myc, p53, HSP70, and HIV tat proteins, J Biol Chem, vol.264, issue.30, pp.18019-18042, 1989.

S. Das and J. E. Dixon, Membrane-binding and activation mechanism of PTEN, Proceedings of the National Academy of Sciences, vol.276, issue.35, pp.7491-7497, 2003.
DOI : 10.1074/jbc.R100007200

B. Dave and R. R. Eason, The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN, Carcinogenesis, vol.26, issue.10, pp.1793-803, 2005.
DOI : 10.1046/j.1365-2184.36.s.1.3.x

K. Degenhardt and G. Chen, BAX and BAK mediate p53-independent suppression of tumorigenesis, Cancer Cell, vol.2, issue.3, pp.193-203, 2002.
DOI : 10.1016/S1535-6108(02)00126-5

A. B. Deleo and G. Jay, Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse., Proceedings of the National Academy of Sciences, vol.76, issue.5, pp.2420-2424, 1979.
DOI : 10.1073/pnas.76.5.2420

D. Cristofano, A. , and P. Kotsi, Impaired Fas Response and Autoimmunity in Pten+/ Mice, Science, vol.285, issue.5436, pp.2122-2127, 1999.
DOI : 10.1126/science.285.5436.2122

D. Cristofano, A. , and B. Pesce, Pten is essential for embryonic development and tumour suppression, Nature Genetics, vol.225, issue.4, pp.348-55, 1998.
DOI : 10.1016/0076-6879(93)25057-9

G. Dolivet and P. Colosetti, [Elements of epidemiology and initiation of carcinogenesis in carcinomas of the upper aerodigestive tract. Future therapeutic consequence?], Rev Laryngol Otol Rhinol (Bord), vol.120, issue.1, pp.5-12, 1999.

G. Dolivet and J. L. Merlin, In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector, Cancer Gene Therapy, vol.15, issue.8, pp.708-722, 2002.
DOI : 10.1200/JCO.1997.15.3.1030

L. A. Donehower and M. Harvey, Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours, Nature, vol.356, issue.6366, pp.215-236, 1992.
DOI : 10.1038/356215a0

C. P. Downes and S. Ross, Stimulation of PI 3-kinase signaling via inhibition of the tumor suppressor phosphatase, PTEN, Advances in Enzyme Regulation, vol.47, issue.1, pp.184-94, 2007.
DOI : 10.1016/j.advenzreg.2006.12.018

F. Edwin and R. Singh, The Tumor Suppressor PTEN Is Necessary for Human Sprouty 2-mediated Inhibition of Cell Proliferation, Journal of Biological Chemistry, vol.12, issue.8, pp.4816-4838, 2006.
DOI : 10.1016/S0960-9822(00)00417-6

H. E. Feilotter and M. A. Nagai, Analysis of PTEN and the 10q23 region in primary prostate carcinomas, Oncogene, vol.16, issue.13, pp.1743-1751, 1998.
DOI : 10.1038/sj.onc.1200205

P. L. Felgner and T. R. Gadek, Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure., Proceedings of the National Academy of Sciences, vol.84, issue.21, pp.7413-7420, 1987.
DOI : 10.1073/pnas.84.21.7413

J. Feng and J. Park, Identification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein Kinase, Journal of Biological Chemistry, vol.217, issue.39, pp.41189-96, 2004.
DOI : 10.1074/jbc.M303083200

S. Ferrari and E. Moro, ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo, Gene Therapy, vol.4, issue.10, pp.1100-1106, 1997.
DOI : 10.1038/sj.gt.3300503

B. Ferraro and G. Bepler, and Survival in Patients With Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.23, issue.9, pp.1921-1927, 2005.
DOI : 10.1200/JCO.2005.08.127

S. Fields and S. K. Jang, Presence of a potent transcription activating sequence in the p53 protein, Science, vol.249, issue.4972, pp.1046-1055, 1990.
DOI : 10.1126/science.2144363

M. Frattini and P. Saletti, PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients, British Journal of Cancer, vol.24, issue.8, pp.1139-1184, 2007.
DOI : 10.1016/j.ctrv.2003.10.003

D. A. Freedman and A. J. Levine, Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6, Molecular and Cellular Biology, vol.18, issue.12, pp.7288-93, 1998.
DOI : 10.1128/MCB.18.12.7288

M. Fukuoka and S. Yano, Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.21, issue.12, pp.2237-2283, 2003.
DOI : 10.1200/JCO.2003.10.038

E. Galanis and S. H. Okuno, Phase I???II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas, Gene Therapy, vol.89, issue.5, pp.437-482, 2005.
DOI : 10.1093/jnci/89.15.1138

F. Gebhardt and K. S. Zanker, Modulation of Epidermal Growth Factor Receptor Gene Transcription by a Polymorphic Dinucleotide Repeat in Intron 1, Journal of Biological Chemistry, vol.269, issue.19, pp.13176-80, 1999.
DOI : 10.1093/nar/21.4.1047

R. K. Geyer and Z. K. Yu, The MDM2 RING-finger domain is required to promote p53 nuclear export, Nature Cell Biology, vol.13, issue.9, pp.569-73, 2000.
DOI : 10.1128/MCB.13.9.5186

O. Gimm and A. Perren, Differential Nuclear and Cytoplasmic Expression of PTEN in Normal Thyroid Tissue, and Benign and Malignant Epithelial Thyroid Tumors, The American Journal of Pathology, vol.156, issue.5, pp.1693-700, 2000.
DOI : 10.1016/S0002-9440(10)65040-7

W. T. Godbey and K. K. Wu, Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency, Gene Therapy, vol.68, issue.8, pp.1380-1388, 1999.
DOI : 10.1073/pnas.80.12.3734

D. W. Goodrich and W. H. Lee, The molecular genetics of retinoblastoma, Cancer Surv, vol.9, issue.3, pp.529-54, 1990.

V. Gottifredi and C. Prives, MOLECULAR BIOLOGY: Getting p53 Out of the Nucleus, Science, vol.292, issue.5523, pp.1851-1853, 2001.
DOI : 10.1126/science.1062238

D. R. Green and J. E. Chipuk, p53 and Metabolism: Inside the TIGAR, Cell, vol.126, issue.1, pp.30-32, 2006.
DOI : 10.1016/j.cell.2006.06.032

K. Gronbaek and J. Zeuthen, Alterations of the MMAC1/PTEN gene in lymphoid malignancies, Blood, vol.91, issue.11, pp.4388-90, 1998.

J. Gu and M. Tamura, Tumor Suppressor PTEN Inhibits Integrin- and Growth Factor???mediated Mitogen-activated Protein (MAP) Kinase Signaling Pathways, The Journal of Cell Biology, vol.17, issue.5, pp.1375-83, 1998.
DOI : 10.1016/0955-0674(95)80110-3

G. Guasch, Dérégulation moléculaire et cancer: prolifération, survie et inhibition de l'apoptose, the international ImMunoGeneTics information system*, 2002.

P. Guldberg and P. Thor-straten, Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma, Cancer Res, vol.57, issue.17, pp.3660-3663, 1997.

S. R. Hall and L. E. Campbell, Phosphorylation of p53 at the casein kinase II site selectively regulates p53-dependent transcriptional repression but not transactivation, Nucleic Acids Research, vol.24, issue.6, pp.1119-1145, 1996.
DOI : 10.1093/nar/24.6.1119

S. Han and J. Roman, Rosiglitazone suppresses human lung carcinoma cell growth through PPAR??-dependent and PPAR??-independent signal pathways, Molecular Cancer Therapeutics, vol.5, issue.2, pp.430-437, 2006.
DOI : 10.1158/1535-7163.MCT-05-0347

E. Harlow and D. C. Pim, Complex of simian virus 40 large-T antigen and host 53,000-molecular-weight protein in monkey cells, J Virol, vol.37, issue.2, pp.564-73, 1981.

S. Haupt and Y. Haupt, Importance of p53 for cancer onset and therapy, Anti-Cancer Drugs, vol.17, issue.7, pp.725-757, 2006.
DOI : 10.1097/01.cad.0000217422.52208.fa

Y. Haupt and R. Maya, Mdm2 promotes the rapid degradation of p53, Nature, vol.387, issue.6630, pp.296-305, 1997.
DOI : 10.1038/387296a0

C. Heise and A. Sampson-johannes, ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents, Nature Medicine, vol.55, issue.6, pp.639-684, 1997.
DOI : 10.1101/gad.7.4.546

R. S. Herbst, Review of epidermal growth factor receptor biology, International Journal of Radiation Oncology*Biology*Physics, vol.59, issue.2, pp.21-27, 2004.
DOI : 10.1016/j.ijrobp.2003.11.041

R. S. Herbst and W. K. Hong, IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer, Semin Oncol, vol.295, pp.18-30, 2002.

K. Hettinger and F. Vikhanskaya, c-Jun promotes cellular survival by suppression of PTEN, Cell Death and Differentiation, vol.280, issue.2, pp.218-247, 2007.
DOI : 10.1016/S1383-5718(01)00179-6

A. Hlobilkova and J. Knillova, The mechanism of action of the tumour suppressor gene pten, Biomedical Papers, vol.147, issue.1, pp.19-25, 2003.
DOI : 10.5507/bp.2003.003

A. Hogset and L. Prasmickaite, Photochemical internalisation in drug and gene delivery, Advanced Drug Delivery Reviews, vol.56, issue.1, pp.95-115, 2004.
DOI : 10.1016/j.addr.2003.08.016

M. Hollstein and M. J. Marion, p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers, Carcinogenesis, vol.15, issue.1, pp.1-3, 1994.
DOI : 10.1093/carcin/15.1.1

M. Hollstein and D. Sidransky, p53 mutations in human cancers, Science, vol.253, issue.5015, pp.49-53, 1991.
DOI : 10.1126/science.1905840

W. Hu and Z. Feng, p53 regulates maternal reproduction through LIF, Nature, vol.10, issue.7170, pp.721-725, 2007.
DOI : 10.1111/j.1600-0897.1998.tb00345.x

A. Huether and M. Hopfner, EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer, Biochemical Pharmacology, vol.70, issue.11, pp.1568-78, 2005.
DOI : 10.1016/j.bcp.2005.09.007

N. Issaeva and P. Bozko, Small molecule RITA binds to p53, blocks p53???HDM-2 interaction and activates p53 function in tumors, Nature Medicine, vol.98, issue.12, pp.1321-1329, 2004.
DOI : 10.1073/pnas.98.3.1218

J. R. Jeffers and E. Parganas, Puma is an essential mediator of p53-dependent and -independent apoptotic pathways, Cancer Cell, vol.4, issue.4, pp.321-329, 2003.
DOI : 10.1016/S1535-6108(03)00244-7

M. B. Kastan and O. Onyekwere, Commentary on "Participation of p53 Protein in the Cellular Response to DNA Damage", Cancer Research, vol.76, issue.13, pp.6304-6315, 1991.
DOI : 10.1158/0008-5472.CAN-16-1560

M. A. Kay and J. C. Glorioso, Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics, Nature Medicine, vol.9, issue.1, pp.33-40, 2001.
DOI : 10.1016/S0958-1669(98)80032-3

A. Kelekar and C. B. Thompson, Bcl-2-family proteins: the role of the BH3 domain in apoptosis, Trends in Cell Biology, vol.8, issue.8, pp.324-354, 1998.
DOI : 10.1016/S0962-8924(98)01321-X

A. Kichler and C. Leborgne, Polyethylenimine-mediated gene delivery: a mechanistic study, The Journal of Gene Medicine, vol.7, issue.2, pp.135-179, 2001.
DOI : 10.1021/bc9600630

K. Kojima and M. Konopleva, Concomitant Inhibition of MDM2 and Bcl-2 Protein Function Synergistically Induce Mitochondrial Apoptosis in AML, Cell Cycle, vol.5, issue.23, pp.2778-86, 2006.
DOI : 10.4161/cc.5.23.3520

M. H. Kubbutat and S. N. Jones, Regulation of p53 stability by Mdm2, Nature, vol.387, issue.6630, pp.299-303, 1997.
DOI : 10.1038/387299a0

J. Kwon and S. R. Lee, Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors, Proceedings of the National Academy of Sciences, vol.332, issue.6165, pp.16419-16443, 2004.
DOI : 10.1038/332644a0

P. F. Lambert and F. Kashanchi, Phosphorylation of p53 Serine 15 Increases Interaction with CBP, Journal of Biological Chemistry, vol.5, issue.49, pp.33048-53, 1998.
DOI : 10.1038/sj.onc.1201244

D. P. Lane and L. V. Crawford, T antigen is bound to a host protein in SY40-transformed cells, Nature, vol.29, issue.5701, pp.261-264, 1979.
DOI : 10.1016/0042-6822(78)90171-X

J. O. Lee and H. Yang, Crystal Structure of the PTEN Tumor Suppressor, Cell, vol.99, issue.3, pp.323-357, 1999.
DOI : 10.1016/S0092-8674(00)81663-3

N. R. Leslie and D. Bennett, Redox regulation of PI 3-kinase signalling via inactivation of PTEN, The EMBO Journal, vol.22, issue.20, pp.5501-5511, 2003.
DOI : 10.1093/emboj/cdg513

D. M. Li and H. Sun, TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta, Cancer Res, vol.57, issue.11, pp.2124-2133, 1997.

J. Li and C. Yen, PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer, Science, vol.275, issue.5308, pp.1943-1950, 1997.
DOI : 10.1126/science.275.5308.1943

X. Li and R. Luwor, Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells, Oncogene, vol.25, issue.4, pp.525-560, 2006.
DOI : 10.1038/sj.onc.1209075

Z. Li and X. Dong, Regulation of PTEN by Rho small GTPases, Nature Cell Biology, vol.4, issue.4, pp.399-404, 2005.
DOI : 10.1038/ni892

A. Lievre and J. B. Bachet, Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab, Journal of Clinical Oncology, vol.26, issue.3, pp.374-383, 2008.
DOI : 10.1200/JCO.2007.12.5906

URL : https://hal.archives-ouvertes.fr/hal-00363737

D. I. Linzer and W. Maltzman, The SV40 a gene product is required for the production of a 54,000 MW cellular tumor antigen, Virology, vol.98, issue.2, pp.308-326, 1979.
DOI : 10.1016/0042-6822(79)90554-3

J. L. Liu and X. Sheng, Nuclear PTEN-Mediated Growth Suppression Is Independent of Akt Down-Regulation, Molecular and Cellular Biology, vol.25, issue.14, pp.6211-6235, 2005.
DOI : 10.1128/MCB.25.14.6211-6224.2005

M. Longy and V. Coulon, Mutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotype., Journal of Medical Genetics, vol.35, issue.11, pp.886-895, 1998.
DOI : 10.1136/jmg.35.11.886

H. Lu and A. J. Levine, Human TAFII31 protein is a transcriptional coactivator of the p53 protein., Proceedings of the National Academy of Sciences, vol.92, issue.11, pp.5154-5162, 1995.
DOI : 10.1073/pnas.92.11.5154

T. Maehama and J. E. Dixon, The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate, Journal of Biological Chemistry, vol.317, issue.22, pp.13375-13383, 1998.
DOI : 10.1016/S0092-8674(00)80272-X

L. Mahimainathan and F. Das, Mesangial Cell Hypertrophy by High Glucose Is Mediated by Downregulation of the Tumor Suppressor PTEN, Diabetes, vol.55, issue.7, pp.2115-2140, 2006.
DOI : 10.2337/db05-1326

D. Malkin and F. P. Li, Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms, Science, vol.250, issue.4985, pp.1233-1241, 1990.
DOI : 10.1126/science.1978757

D. J. Marsh and V. Coulon, Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation, Human Molecular Genetics, vol.7, issue.3, pp.507-522, 1998.
DOI : 10.1093/hmg/7.3.507

D. J. Marsh and P. L. Dahia, Germline mutations in PTEN are present in Bannayan-Zonana syndrome, Nature Genetics, vol.112, issue.4, pp.333-337, 1997.
DOI : 10.1001/jama.276.19.1575

C. P. Martins and L. Brown-swigart, Modeling the Therapeutic Efficacy of p53 Restoration in Tumors, Cell, vol.127, issue.7, pp.1323-1357, 2006.
DOI : 10.1016/j.cell.2006.12.007

P. May and E. May, Twenty years of p53 research: structural and functional aspects of the p53 protein, Oncogene, vol.18, issue.53, pp.7621-7657, 1999.
DOI : 10.1038/372773a0

G. Mazzotti and N. Zini, Immunocytochemical detection of phosphatidylinositol 4,5-bisphosphate localization sites within the nucleus., Journal of Histochemistry & Cytochemistry, vol.43, issue.2, pp.181-91, 1995.
DOI : 10.1177/43.2.7822774

J. Merlin and G. Perkins, mutation for response prediction to cetuximab in colorectal cancer (CRC), Journal of Clinical Oncology, vol.26, issue.15_suppl, p.209, 2008.
DOI : 10.1200/jco.2008.26.15_suppl.4126

J. L. Merlin and G. Dolivet, Improvement of nonviral p53 gene transfer in human carcinoma cells using glucosylated polyethylenimine derivatives, Cancer Gene Therapy, vol.8, issue.3, pp.203-213, 2001.
DOI : 10.1038/sj.cgt.7700289

T. Miyashita and J. C. Reed, Tumor suppressor p53 is a direct transcriptional activator of the human bax gene, Cell, vol.80, issue.2, pp.293-302, 1995.

J. Momand and G. P. Zambetti, The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation, Cell, vol.69, issue.7, pp.1237-1282, 1992.
DOI : 10.1016/0092-8674(92)90644-R

L. Monnier and G. Milano, [Targeting of membrane receptor tyrosine kinases: is there resistance in the HER, Bull Cancer, vol.91, issue.9, pp.685-94, 2004.

A. Mora and D. Komander, PDK1, the master regulator of AGC kinase signal transduction, Seminars in Cell & Developmental Biology, vol.15, issue.2, pp.161-70, 2004.
DOI : 10.1016/j.semcdb.2003.12.022

M. Moroni and S. Veronese, Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study, The Lancet Oncology, vol.6, issue.5, pp.279-86, 2005.
DOI : 10.1016/S1470-2045(05)70102-9

M. Muller and S. Wilder, p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs, The Journal of Experimental Medicine, vol.54, issue.11, pp.2033-2078, 1998.
DOI : 10.1038/ng1097-141

Y. Nakahara and H. Nagai, Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin???s lymphoma, Leukemia, vol.12, issue.8, pp.1277-80, 1998.
DOI : 10.1038/sj.leu.2401099

K. Nakano and K. H. Vousden, PUMA, a Novel Proapoptotic Gene, Is Induced by p53, Molecular Cell, vol.7, issue.3, pp.683-94, 2001.
DOI : 10.1016/S1097-2765(01)00214-3

N. T. Nassif and G. P. Lobo, PTEN mutations are common in sporadic microsatellite stable colorectal cancer, Oncogene, vol.23, issue.2, pp.617-645, 2004.
DOI : 10.1016/S0002-9440(10)64200-9

A. Ndoye and G. Dolivet, Eradication of p53-Mutated Head and Neck Squamous Cell Carcinoma Xenografts Using Nonviral p53 Gene Therapy and Photochemical Internalization, Molecular Therapy, vol.13, issue.6, pp.1156-62, 2006.
DOI : 10.1016/j.ymthe.2006.02.003

URL : https://hal.archives-ouvertes.fr/hal-00129944

J. Nemunaitis and N. Senzer, A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients, Cancer Gene Therapy, vol.72, issue.11, pp.885-93, 2007.
DOI : 10.1016/j.ymeth.2005.11.005

D. W. Nicholson and N. A. Thornberry, APOPTOSIS: Life and Death Decisions, Science, vol.299, issue.5604, pp.214-219, 2003.
DOI : 10.1126/science.1081274

J. M. Nigro and S. J. Baker, Mutations in the p53 gene occur in diverse human tumour types, Nature, vol.342, issue.6250, pp.705-713, 1989.
DOI : 10.1038/342705a0

O. 'brate, A. , and P. Giannakakou, The importance of p53 location: nuclear or cytoplasmic zip code?, Drug Resist Updat, vol.6, issue.6, pp.313-335, 2003.

S. Ogino and J. A. Meyerhardt, Molecular Alterations in Tumors and Response to Combination Chemotherapy with Gefitinib for Advanced Colorectal Cancer, Clinical Cancer Research, vol.11, issue.18, pp.6650-6656, 2005.
DOI : 10.1158/1078-0432.CCR-05-0738

F. Okahara and H. Ikawa, Regulation of PTEN Phosphorylation and Stability by a Tumor Suppressor Candidate Protein, Journal of Biological Chemistry, vol.169, issue.44, pp.45300-45303, 2004.
DOI : 10.1126/science.1092089

F. Okahara and K. Itoh, Critical Role of PICT-1, a Tumor Suppressor Candidate, in Phosphatidylinositol 3,4,5-Trisphosphate Signals and Tumorigenic Transformation, Molecular Biology of the Cell, vol.17, issue.11, pp.4888-95, 2006.
DOI : 10.1091/mbc.E06-04-0301

A. Okamura and N. Iwata, Casein kinase I?? down-regulates phospho-Akt via PTEN, following genotoxic stress-induced apoptosis in hematopoietic cells, Life Sciences, vol.78, issue.14, pp.1624-1633, 2006.
DOI : 10.1016/j.lfs.2005.07.041

H. Okamura and K. Yoshida, PTEN expression elicited byEGR-1 transcription factor in calyculin A-induced apoptotic cells, Journal of Cellular Biochemistry, vol.14, issue.1, pp.117-142, 2005.
DOI : 10.1038/sj.gt.3300598

J. D. Oliner and J. A. Pietenpol, Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53, Nature, vol.362, issue.6423, pp.857-60, 1993.
DOI : 10.1038/362857a0

M. Oren and W. Maltzman, Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells., Molecular and Cellular Biology, vol.1, issue.2, pp.101-111, 1981.
DOI : 10.1128/MCB.1.2.101

K. Ory and Y. Legros, Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation, Embo J, vol.13, issue.15, pp.3496-504, 1994.

E. A. Papakonstanti and A. J. Ridley, The p110?? isoform of PI 3-kinase negatively controls RhoA and PTEN, The EMBO Journal, vol.19, issue.13, pp.3050-61, 2007.
DOI : 10.4049/jimmunol.170.5.2647

O. J. Park and Y. J. Surh, Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies, Toxicology Letters, vol.150, issue.1, pp.43-56, 2004.
DOI : 10.1016/j.toxlet.2003.06.001

L. Patel and I. Pass, Tumor suppressor and anti-inflammatory actions of PPAR?? agonists are mediated via upregulation of PTEN, Current Biology, vol.11, issue.10, pp.764-772, 2001.
DOI : 10.1016/S0960-9822(01)00225-1

A. Perren and L. P. Weng, Immunohistochemical Evidence of Loss of PTEN Expression in Primary Ductal Adenocarcinomas of the Breast, The American Journal of Pathology, vol.155, issue.4, pp.1253-60, 1999.
DOI : 10.1016/S0002-9440(10)65227-3

F. Perrone and A. Lampis, PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients, Annals of Oncology, vol.13, issue.44, 2008.
DOI : 10.3748/wjg.v13.i44.5877

M. E. Perry and J. Piette, The mdm-2 gene is induced in response to UV light in a p53-dependent manner., Proceedings of the National Academy of Sciences, vol.90, issue.24, pp.90-11623, 1993.
DOI : 10.1073/pnas.90.24.11623

N. Personeni and J. D. Schutter, Response prediction to cetuximab-based therapy: The role of EGFR copy number by fluorescence in situ hybridization and downstream effectors gene mutations, Gastrointestinal Cancers Symposium abstract 400

K. Podsypanina and L. H. Ellenson, Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems, Proceedings of the National Academy of Sciences, vol.8, issue.21, pp.1563-1571, 1999.
DOI : 10.1016/S0960-9822(07)00488-5

L. Prasmickaite and A. Hogset, Evaluation of Different Photosensitizers for Use in Photochemical Gene Transfection??, Photochemistry and Photobiology, vol.10, issue.4, pp.388-95, 2001.
DOI : 10.1562/0031-8655(2000)072<0554:UEEOAR>2.0.CO;2

M. Prewett and P. Rockwell, The Biologic Effects of C225, A Chimeric Monoclonal Antibody to the EGFR, on Human Prostate Carcinoma, Journal of Immunotherapy, vol.19, issue.6, pp.419-446, 1996.
DOI : 10.1097/00002371-199611000-00006

M. Qi and A. E. Anderson, Indole-3-carbinol prevents PTEN loss in cervical cancer in vivo, Mol Med, vol.11, issue.112, pp.59-63, 2005.

E. Razis and E. Briasoulis, Potential value of PTEN in predicting cetuximab response in colorectal cancer: An exploratory study, BMC Cancer, vol.112, issue.3, p.234, 2008.
DOI : 10.1002/ijc.20447

T. M. Rippin and V. J. Bykov, Characterization of the p53-rescue drug CP-31398 in vitro and in living cells, Oncogene, vol.21, issue.14, pp.2119-2148, 2002.
DOI : 10.1073/pnas.96.15.8438

P. D. Robbins and H. Tahara, Viral vectors for gene therapy, Trends in Biotechnology, vol.16, issue.1, pp.35-40, 1998.
DOI : 10.1016/S0167-7799(97)01137-2

G. P. Robertson and F. B. Furnari, In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma, Proceedings of the National Academy of Sciences, vol.56, issue.9, pp.95-9418, 1998.
DOI : 10.1002/gcc.2870120404

E. Romagnani and V. Martin, EGFR gene status, K-Ras mutation and PTEN expression predict cetuximab response in metastatic colorectal cancer, Gastrointestinal Cancers Symposium: Abstract 427

K. Sakaguchi and J. E. Herrera, DNA damage activates p53 through a phosphorylation-acetylation cascade, Genes & Development, vol.12, issue.18, pp.2831-2872, 1998.
DOI : 10.1101/gad.12.18.2831

A. Sakai and C. Thieblemont, PTEN gene alterations in lymphoid neoplasms, Blood, vol.92, issue.9, pp.3410-3415, 1998.

D. D. Sarbassov and D. A. Guertin, Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex, Science, vol.307, issue.5712, pp.1098-101, 2005.
DOI : 10.1126/science.1106148

P. K. Selbo and A. Hogset, Photochemical Internalisation: A Novel Drug Delivery System, Tumor Biology, vol.23, issue.2, pp.103-115, 2002.
DOI : 10.1159/000059713

J. H. Seo and Y. Ahn, The Major Target of the Endogenously Generated Reactive Oxygen Species in Response to Insulin Stimulation Is Phosphatase and Tensin Homolog and Not Phosphoinositide-3 Kinase (PI-3 Kinase) in the PI-3 Kinase/Akt Pathway, Molecular Biology of the Cell, vol.16, issue.1, pp.348-57, 2005.
DOI : 10.1091/mbc.E04-05-0369

Q. B. She and D. Solit, Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3' -kinase/Akt pathway signaling, Clin Cancer Res, vol.9, issue.12, pp.4340-4346, 2003.

Y. H. Shen and L. Zhang, Up-regulation of PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome Ten) Mediates p38 MAPK Stress Signal-induced Inhibition of Insulin Signaling, Journal of Biological Chemistry, vol.7, issue.12, pp.7727-7763, 2006.
DOI : 10.1074/jbc.272.50.31400

K. Somasundaram, Tumor suppressor p53: regulation and function, Frontiers in Bioscience, vol.5, issue.1, pp.424-461, 2000.
DOI : 10.2741/Somasund

T. Soussi and C. Beroud, Assessing TP53 status in human tumours to evaluate clinical outcome, Nature Reviews Cancer, vol.91, issue.3, pp.233-273, 2001.
DOI : 10.1111/j.1349-7006.2000.tb00931.x

T. Soussi and C. Caron-de-fromentel, Structural aspects of the p53 protein in relation to gene evolution, Oncogene, vol.5, issue.7, pp.945-52, 1990.

T. Soussi and G. Lozano, p53 mutation heterogeneity in cancer, Biochemical and Biophysical Research Communications, vol.331, issue.3, pp.834-876, 2005.
DOI : 10.1016/j.bbrc.2005.03.190

S. Srivastava and Z. Q. Zou, Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li???Fraumeni syndrome, Nature, vol.348, issue.6303, pp.747-756, 1990.
DOI : 10.1038/348747a0

V. Stambolic and A. Suzuki, Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN, Cell, vol.95, issue.1, pp.29-39, 1998.
DOI : 10.1016/S0092-8674(00)81780-8

P. A. Steck and M. A. Pershouse, Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers, Nature Genetics, vol.263, issue.4, pp.356-62, 1997.
DOI : 10.1038/ng0696-241

C. L. Stewart and A. M. Soria, Integration of the pRB and p53 cell cycle control pathways, Journal of Neuro-Oncology, vol.51, issue.3, pp.183-204, 2001.
DOI : 10.1023/A:1010615822317

J. A. Stuckey and H. L. Schubert, Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 ?? and the complex with tungstate, Nature, vol.370, issue.6490, pp.571-576, 1994.
DOI : 10.1038/370571a0

J. D. Su and L. D. Mayo, PTEN and phosphatidylinositol 3' -kinase inhibitors upregulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment, Cancer Res, vol.63, issue.13, pp.3585-92, 2003.

M. C. Subauste and P. Nalbant, Vinculin Controls PTEN Protein Level by Maintaining the Interaction of the Adherens Junction Protein ??-Catenin with the Scaffolding Protein MAGI-2, Journal of Biological Chemistry, vol.4, issue.7, pp.5676-81, 2005.
DOI : 10.1006/mcne.2002.1115

H. Sun and R. Lesche, PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway, Proceedings of the National Academy of Sciences, vol.95, issue.1, pp.96-6199, 1999.
DOI : 10.1016/S0092-8674(00)81780-8

Y. Takahashi and F. C. Morales, PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling, The EMBO Journal, vol.94, issue.4, pp.910-930, 2006.
DOI : 10.1042/bj2980517

H. Tanaka and N. Fujita, 3-Phosphoinositide-dependent Protein Kinase-1-mediated I??B Kinase ?? (IKKB) Phosphorylation Activates NF-??B Signaling, Journal of Biological Chemistry, vol.63, issue.49, pp.40965-73, 2005.
DOI : 10.1126/science.281.5385.2042

J. Torres and R. Pulido, The Tumor Suppressor PTEN Is Phosphorylated by the Protein Kinase CK2 at Its C Terminus, Journal of Biological Chemistry, vol.37, issue.2, pp.993-1001, 2001.
DOI : 10.1016/S0959-8049(00)00366-X

L. C. Trotman and X. Wang, Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppression, Cell, vol.128, issue.1, pp.141-56, 2007.
DOI : 10.1016/j.cell.2006.11.040

T. Tuting and C. C. Wilson, Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha, J Immunol, vol.160, issue.3, pp.1139-1186, 1998.

M. Valiente and A. Andres-pons, Binding of PTEN to Specific PDZ Domains Contributes to PTEN Protein Stability and Phosphorylation by Microtubule-associated Serine/Threonine Kinases, Journal of Biological Chemistry, vol.61, issue.32, pp.28936-28979, 2005.
DOI : 10.1016/S1535-6108(03)00331-3

D. Vallbohmer and W. Zhang, Molecular Determinants of Cetuximab Efficacy, Journal of Clinical Oncology, vol.23, issue.15, pp.3536-3580, 2005.
DOI : 10.1200/JCO.2005.09.100

E. Vattemi and P. P. Claudio, Adenoviral gene therapy in head and neck cancer, Drug News & Perspectives, vol.19, issue.6, pp.329-366, 2006.
DOI : 10.1358/dnp.2006.19.6.1015352

F. Vazquez and P. Devreotes, Regulation of PTEN Function as a PIP3 Gatekeeper Through Membrane Interaction, Cell Cycle, vol.5, issue.14, pp.1523-1530, 2006.
DOI : 10.4161/cc.5.14.3005

F. Vazquez and S. Ramaswamy, Phosphorylation of the PTEN Tail Regulates Protein Stability and Function, Molecular and Cellular Biology, vol.20, issue.14, pp.5010-5018, 2000.
DOI : 10.1128/MCB.20.14.5010-5018.2000

G. G. Vecil and F. F. Lang, Clinical Trials of Adenoviruses in Brain Tumors: A Review of Ad-p53 and Oncolytic Adenoviruses, Journal of Neuro-Oncology, vol.65, issue.3, pp.237-283, 2003.
DOI : 10.1023/B:NEON.0000003653.45635.32

C. Venot and M. Maratrat, The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression, The EMBO Journal, vol.17, issue.16, pp.4668-79, 1998.
DOI : 10.1093/emboj/17.16.4668

A. Ventura and D. G. Kirsch, Restoration of p53 function leads to tumour regression in vivo, Nature, vol.119, issue.7128, pp.661-666, 2007.
DOI : 10.1016/j.cell.2004.11.004

M. Verheus and C. H. Van-gils, Plasma Phytoestrogens and Subsequent Breast Cancer Risk, Journal of Clinical Oncology, vol.25, issue.6, pp.648-55, 2007.
DOI : 10.1200/JCO.2006.06.0244

T. Virolle and E. D. Adamson, The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling, Nature Cell Biology, vol.17, issue.12, pp.1124-1132, 2001.
DOI : 10.1083/jcb.17.2.299

K. H. Vousden, Switching from life to death: The Miz-ing link between Myc and p53, Cancer Cell, vol.2, issue.5, pp.351-353, 2002.
DOI : 10.1016/S1535-6108(02)00186-1

K. A. Waite and C. Eng, Protean PTEN: Form and Function, The American Journal of Human Genetics, vol.70, issue.4, pp.829-873, 2002.
DOI : 10.1086/340026

K. A. Waite and M. R. Sinden, Phytoestrogen exposure elevates PTEN levels, Human Molecular Genetics, vol.14, issue.11, pp.1457-63, 2005.
DOI : 10.1073/pnas.76.9.4350

X. Wang and L. C. Trotman, NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN, Cell, vol.128, issue.1, pp.129-168, 2007.
DOI : 10.1016/j.cell.2006.11.039

X. W. Wang and W. Vermeulen, The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway., Genes & Development, vol.10, issue.10, pp.1219-1251, 1996.
DOI : 10.1101/gad.10.10.1219

Y. Wang and C. Prives, Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases, Nature, vol.376, issue.6535, pp.88-91, 1995.
DOI : 10.1038/376088a0

L. Wasungu and D. Hoekstra, Cationic lipids, lipoplexes and intracellular delivery of genes, Journal of Controlled Release, vol.116, issue.2, pp.255-64, 2006.
DOI : 10.1016/j.jconrel.2006.06.024

Y. E. Whang and X. Wu, Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression, Proceedings of the National Academy of Sciences, vol.94, issue.17, pp.5246-50, 1998.
DOI : 10.1073/pnas.94.17.9052

K. G. Wiman, Restoration of Wild???Type p53 Function in Human Tumors: Strategies for Efficient Cancer Therapy, Adv Cancer Res, vol.97, pp.321-359, 2007.
DOI : 10.1016/S0065-230X(06)97014-6

J. A. Wolff and M. E. Dowty, Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle, J Cell Sci, vol.103, pp.1249-59, 1992.

T. K. Wong and E. Neumann, Electric field mediated gene transfer, Biochemical and Biophysical Research Communications, vol.107, issue.2, pp.584-591, 1982.
DOI : 10.1016/0006-291X(82)91531-5

R. A. Woo and K. G. Mclure, DNA-dependent protein kinase acts upstream of p53 in response to DNA damage, Nature, vol.11, issue.6694, pp.700-704, 1998.
DOI : 10.1128/MCB.11.1.12

G. S. Wu and T. F. Burns, KILLER/DR5 is a DNA damage???inducible p53???regulated death receptor gene, Nature Genetics, vol.54, issue.2, pp.141-144, 1997.
DOI : 10.1126/science.277.5327.818

Y. Wu and D. Dowbenko, Interaction of the Tumor Suppressor PTEN/MMAC with a PDZ Domain of MAGI3, a Novel Membrane-associated Guanylate Kinase, Journal of Biological Chemistry, vol.283, issue.28, pp.21477-85, 2000.
DOI : 10.1083/jcb.138.4.845

D. Xia and H. Srinivas, Mitogen-activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression through an NF??B-dependent Pathway, Journal of Biological Chemistry, vol.282, issue.6, pp.3507-3526, 2007.
DOI : 10.1074/jbc.M610141200

Y. Yarden, The EGFR family and its ligands in human cancer, European Journal of Cancer, vol.37, issue.4, pp.3-8, 2001.
DOI : 10.1016/S0959-8049(01)00230-1

J. H. Yim and Y. J. Kim, The putative tumor suppressor gene GLTSCR2 induces PTEN-modulated cell death, Cell Death & Differentiation, vol.199, issue.11, pp.1872-1881, 2007.
DOI : 10.1038/sj.cdd.4402204

C. Yin and C. M. Knudson, Bax suppresses tumorigenesis and stimulates apoptosis in vivo, Nature, vol.385, issue.6617, pp.637-677, 1997.
DOI : 10.1038/385637a0

J. Yu and Z. Wang, PUMA mediates the apoptotic response to p53 in colorectal cancer cells, Proceedings of the National Academy of Sciences, vol.275, issue.5302, pp.1931-1937, 2003.
DOI : 10.1126/science.275.5302.967

W. Zhang and M. Gordon, Two immunoglobulin G fragment C receptor polymorphisms associated with clinical outcome of EGFR-expressing metastatic colorectal cancer patients treated with single agent cetuximab, J Clin Oncol, vol.3028, 2006.

W. Zhang and N. Wu, PPAR?? activator rosiglitazone inhibits cell migration via upregulation of PTEN in human hepatocarcinoma cell line BEL-7404, Cancer Biology & Therapy, vol.5, issue.8, pp.1008-1022, 2006.
DOI : 10.4161/cbt.5.8.2887